Chronic kidney disease (CKD) and hypertension in Bury

Greater ManchesterRenal and Urogenital
Start Date: 1 Aug 2014 End Date: 1 Apr 2016

Chronic kidney disease (CKD) and hypertension in Bury

Aim of the project

This is a one year project (that has recently been extended) to spread the CKD IMPAKT™ work across NHS Bury Clinical Commissioning Group. This work aims to increase the knowledge of healthcare professionals and improve the quality of services and care provided to CKD patients.

Relevance

Excess cardiovascular disease related to CKD is thought to cost the NHS in England £175 million each year. With end stage CKD growing at an estimated 6% per annum, diagnosing and treating CKD effectively as early as possible is hugely important.

This project will aim to result in:

  • Potential decreases in referrals to secondary care
  • Primary care clinicians being more confident in the management of CKD
  • An increase in CKD diagnoses (finding patients with CKD who do not currently have a diagnosis)
  • Improvements in the management of CKD patients
  • Primary care staff being more confident in the use of quality improvement methods which can be transferred to other long-term conditions
  • An increased spread and sustainability of the project across a whole CCG.

Methodology

The research team will be focussing on halving the gap between the recorded and estimated prevalence of CKD on practice registers. We will also be working towards 75% of CKD patients being tested for proteinuria and managed to National Institute for Health and Care Excellence (NICE) recommended blood pressure targets.

Contact 
Dr Tom Blakeman
tom.blakeman@manchester.ac.uk